OS Therapies Inc — All Filings
201 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
3/A
4
4/A
424B3
424B4
424B5
424B7
5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
NT 10-K
NT 10-Q
POS AM
PRE 14A
RW
S-1
S-1/A
S-3
S-8
SC 13G
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
SP 15D2
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| D | — | 0001795091-26-000002 | Mar 6, 2026 | — |
| 8-K | CURRENT REPORT | 0001213900-26-024726 | Mar 6, 2026 | Mar 4, 2026 |
| 4 | — | 0001213900-26-016508 | Feb 13, 2026 | Jan 22, 2026 |
| 4 | — | 0001213900-26-016506 | Feb 13, 2026 | Jan 22, 2026 |
| 4 | — | 0001213900-26-016503 | Feb 13, 2026 | Jan 22, 2026 |
| 4 | — | 0001213900-26-016501 | Feb 13, 2026 | Jan 22, 2026 |
| 4 | — | 0001213900-26-016499 | Feb 13, 2026 | Jan 22, 2026 |
| 4 | — | 0001213900-26-016497 | Feb 13, 2026 | Jan 22, 2026 |
| 4 | — | 0001213900-26-016495 | Feb 13, 2026 | Jan 22, 2026 |
| 4 | — | 0001213900-26-016494 | Feb 13, 2026 | Jan 22, 2026 |
| 4/A | — | 0001213900-26-016435 | Feb 13, 2026 | Oct 21, 2025 |
| 8-K | CURRENT REPORT | 0001213900-26-016408 | Feb 13, 2026 | Feb 10, 2026 |
| D | — | 0001795091-26-000001 | Jan 20, 2026 | — |
| 8-K | CURRENT REPORT | 0001213900-26-003166 | Jan 12, 2026 | Jan 10, 2026 |
| 4 | — | 0001213900-25-124000 | Dec 19, 2025 | Oct 21, 2025 |
| 4 | — | 0001213900-25-123999 | Dec 19, 2025 | Oct 21, 2025 |
| 4 | — | 0001213900-25-123998 | Dec 19, 2025 | Oct 21, 2025 |
| 4 | — | 0001213900-25-123996 | Dec 19, 2025 | Oct 21, 2025 |
| 4 | — | 0001213900-25-123995 | Dec 19, 2025 | Oct 21, 2025 |
| 4 | — | 0001213900-25-123994 | Dec 19, 2025 | Oct 21, 2025 |
| 4 | — | 0001213900-25-123993 | Dec 19, 2025 | Oct 21, 2025 |
| 4 | — | 0001213900-25-123992 | Dec 19, 2025 | Oct 21, 2025 |
| 10-Q | QUARTERLY REPORT | 0001213900-25-110829 | Nov 14, 2025 | Sep 30, 2025 |
| S-8 | REGISTRATION STATEMENT | 0001213900-25-104724 | Oct 31, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-100821 | Oct 21, 2025 | — |
| DEFA14A | CURRENT REPORT | 0001213900-25-100025 | Oct 17, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-100019 | Oct 17, 2025 | Oct 14, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-093936 | Sep 30, 2025 | — |
| 424B7 | PROSPECTUS SUPPLEMENT | 0001213900-25-093934 | Sep 30, 2025 | — |
| D | — | 0000921895-25-002566 | Sep 10, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-083396 | Sep 2, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-080484 | Aug 26, 2025 | Aug 25, 2025 |
| ARS | ARS | 0001213900-25-080439 | Aug 26, 2025 | Dec 31, 2024 |
| EFFECT | — | 9999999995-25-002736 | Aug 25, 2025 | — |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0002077096-25-000060 | Aug 25, 2025 | — |
| DEF 14A | PROXY STATEMENT | 0001213900-25-080407 | Aug 25, 2025 | Oct 14, 2025 |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-25-080389 | Aug 25, 2025 | — |
| 424B3 | PROSPECTUS | 0001213900-25-080378 | Aug 25, 2025 | — |
| CORRESP | — | 0001213900-25-079387 | Aug 21, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-078152 | Aug 19, 2025 | — |
| SCHEDULE 13D/A | — | 0001641172-25-024711 | Aug 18, 2025 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-25-077916 | Aug 18, 2025 | Jun 30, 2025 |
| PRE 14A | PROXY STATEMENT | 0001213900-25-077465 | Aug 15, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-077431 | Aug 15, 2025 | — |
| NT 10-Q | NOTIFICATION OF LATE FILING | 0001213900-25-076873 | Aug 15, 2025 | Jun 30, 2025 |
| UPLOAD | — | 0000000000-25-008544 | Aug 13, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-077540 | Aug 13, 2025 | — |
| EFFECT | — | 9999999995-25-002586 | Aug 12, 2025 | — |
| S-3 | REGISTRATION STATEMENT | 0001213900-25-073734 | Aug 8, 2025 | — |
| CORRESP | — | 0001213900-25-073722 | Aug 8, 2025 | — |